1 / 5

Trust is good, control is better!

Trust is good, control is better!. Matthias Gessner Baxter AG Vienna, Austria. Background. 71 HCV and 59 HIV commercially available quantified virus preparations were obtained from various vendors and tested with HIQ-PCR Testing in various dilutions by HIQ-PCR in frame of performance study

urvi
Download Presentation

Trust is good, control is better!

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Trust is good, control is better! Matthias Gessner Baxter AG Vienna, Austria

  2. Background • 71 HCV and 59 HIV commercially available quantified virus preparations were obtained from various vendors and tested with HIQ-PCR • Testing in various dilutions by HIQ-PCR in frame of performance study • 11 samples (8%) gave unexpected negative results in the test, i.e. were not detected in spite of a nominally high concentration in the sample • These samples were sent to the Inst. of Virology, Medical Univ. of Vienna for independent quantitative testing • Cobas Amplicor HCV Monitor v2.0 • Cobas Amplicor HIV-1 Monitor v1.5

  3. Viral load according to

  4. Conclusion • Specimens yielding negative or unexpectedly low results showed gross deviation between their stated and actual viral load when re-quantified • Since only samples with very obvious deviations were re-tested, the percentage of commercially available samples with deviating concentration values may be higher • Quantitative information provided with commercially available viral specimens, such as • Clinical samples • Viral preparations • Seroconversion panels may by misleading and thus, needs to be regarded with caution.

More Related